Gut microbiota-derived indole-3-lactic acid suppresses anti-PD-1 efficacy in esophageal squamous cell carcinoma
Cell Host & Microbe · 2026-04 · 34 (4) · 639-656.e10
DOI: 10.1016/j.chom.2026.02.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2026-04. Verfasst von Jianfeng Zhou und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Gastrointestinal Microbiome, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy where the efficacy of anti-PD-1 immunotherapy varies among individuals, possibly influenced by the gut microbiota. Here, we analyze 122 fecal samples from ESCC patients undergoing neoadjuvant immunotherapy and identify an enrichment of Ligilactobacillus salivarius (L. salivarius) in non-responders. Humanized microbiome, orthotopic ESCC mouse models, and single-cell RNA sequencing confirm that L. salivarius-produced indole-3-lactic acid (ILA) suppresses tumor-infiltrating NKG7⁺CD8⁺ Tpex cells, impairing anti-tumor immunity. Moreover, ILA-deficient L. salivarius strains abolish ILA production and immune resistance. In vitro assays reveal that ILA targets the aryl hydrocarbon receptor and downregulates nuclear factor κB (NF-κB) signaling in Tpex cells. Pharmacological NF-κB activation restores Tpex function and reverses resistance. Two validation cohorts support the L. salivarius-ILA-NKG7⁺CD8⁺ Tpex axis as a resistance mechanism in ESCC patients. These findings highlight L. salivarius and ILA as key modulators of the tumor microenvironment, offering potential strategies for overcoming immunotherapy resistance in ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
- Biomedical Big Data Center of West China Hospital, Med-X Center for Informatics, Sichuan University, Chengdu 610041, Sichuan, China; Scientific Center for Biotherapy Translational Medicine of Sichuan University, Nationa…
- Advanced Mass Spectrometry Center, Research Core Facility, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610213, Sichuan, China.
- Biomedical Big Data Center of West China Hospital, Med-X Center for Informatics, Sichuan University, Chengdu 610041, Sichuan, China.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address: dingzhenyu@scu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, J., Zeng, X., Sun, J., Yang, Y., Wang, J., Xiao, X., Fang, P., Liu, Y., Wang, M., Long, Y., Fu, F., Li, W., Du, J., Liang, Z., Nie, S., Luan, S., Li, X., Zhang, H., Peng, Y., …, & Yuan, Y. (2026). Gut microbiota-derived indole-3-lactic acid suppresses anti-PD-1 efficacy in esophageal squamous cell carcinoma. Cell Host & Microbe, 34(4), 639-656.e10. https://doi.org/10.1016/j.chom.2026.02.019
Vancouver
Zhou J, Zeng X, Sun J, Yang Y, Wang J, Xiao X, et al. Gut microbiota-derived indole-3-lactic acid suppresses anti-PD-1 efficacy in esophageal squamous cell carcinoma. Cell Host & Microbe. 2026;34(4):639-656.e10. doi:10.1016/j.chom.2026.02.019
BibTeX
@article{Zhou2026,
author = {Zhou, Jianfeng and Zeng, Xiaoxi and Sun, Jun and Yang, Yushang and Wang, Jian and Xiao, Xin and Fang, Pinhao and Liu, Yixin and Wang, Manjiangcuo and Long, Yijing and Fu, Fei and Li, Wanmeng and Du, Jiajia and Liang, Zhiwen and Nie, Shiqing and Luan, Siyuan and Li, Xiaokun and Zhang, Haowen and Peng, Yuhao and Sun, Shangwei and Zhu, Weitao and Zhang, Lingyun and Shang, Qixin and Chen, Yueyun and Xu, Yuyang and Chen, Longqi and Ding, Zhenyu and Du, Dan and Guo, An-Yuan and Wei, Xiawei and Yuan, Yong},
title = {Gut microbiota-derived indole-3-lactic acid suppresses anti-PD-1 efficacy in esophageal squamous cell carcinoma},
journal = {Cell Host & Microbe},
year = {2026},
volume = {34},
number = {4},
pages = {639--656.e10},
doi = {10.1016/j.chom.2026.02.019}
}
EUVIMED